BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

152 related articles for article (PubMed ID: 24165034)

  • 1. Clinicopathological characteristics at primary melanoma diagnosis as risk factors for brain metastasis.
    Qian M; Ma MW; Fleming NH; Lackaye DJ; Hernando E; Osman I; Shao Y
    Melanoma Res; 2013 Dec; 23(6):461-7. PubMed ID: 24165034
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Predictive factors for the development of brain metastasis in advanced unresectable metastatic melanoma.
    Bedikian AY; Wei C; Detry M; Kim KB; Papadopoulos NE; Hwu WJ; Homsi J; Davies M; McIntyre S; Hwu P
    Am J Clin Oncol; 2011 Dec; 34(6):603-10. PubMed ID: 21150567
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Gene expression profiling of primary cutaneous melanoma and clinical outcome.
    Winnepenninckx V; Lazar V; Michiels S; Dessen P; Stas M; Alonso SR; Avril MF; Ortiz Romero PL; Robert T; Balacescu O; Eggermont AM; Lenoir G; Sarasin A; Tursz T; van den Oord JJ; Spatz A;
    J Natl Cancer Inst; 2006 Apr; 98(7):472-82. PubMed ID: 16595783
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Serum S100B, lactate dehydrogenase and brain metastasis are prognostic factors in patients with distant melanoma metastasis and systemic therapy.
    Weide B; Richter S; Büttner P; Leiter U; Forschner A; Bauer J; Held L; Eigentler TK; Meier F; Garbe C
    PLoS One; 2013; 8(11):e81624. PubMed ID: 24312329
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prognostic factors in 1,521 melanoma patients with distant metastases.
    Barth A; Wanek LA; Morton DL
    J Am Coll Surg; 1995 Sep; 181(3):193-201. PubMed ID: 7670677
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Primary melanoma location on the scalp is an important risk factor for brain metastasis: a study of 1,687 patients with cutaneous head and neck melanomas.
    Huismans AM; Haydu LE; Shannon KF; Quinn MJ; Saw RP; Spillane AJ; Stretch JR; Thompson JF
    Ann Surg Oncol; 2014 Nov; 21(12):3985-91. PubMed ID: 24912613
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Clinical variables and primary tumor characteristics predictive of the development of melanoma brain metastases and post-brain metastases survival.
    Zakrzewski J; Geraghty LN; Rose AE; Christos PJ; Mazumdar M; Polsky D; Shapiro R; Berman R; Darvishian F; Hernando E; Pavlick A; Osman I
    Cancer; 2011 Apr; 117(8):1711-20. PubMed ID: 21472718
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Survival for patients with single and multiple primary melanomas: the genes, environment, and melanoma study.
    Kricker A; Armstrong BK; Goumas C; Thomas NE; From L; Busam K; Kanetsky PA; Gallagher RP; Marrett LD; Groben PA; Gruber SB; Anton-Culver H; Rosso S; Dwyer T; Berwick M;
    JAMA Dermatol; 2013 Aug; 149(8):921-7. PubMed ID: 23784017
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Increased incidence of brain metastases in cutaneous head and neck melanoma.
    Daryanani D; Plukker JT; de Jong MA; Haaxma-Reiche H; Nap R; Kuiper H; Hoekstra HJ
    Melanoma Res; 2005 Apr; 15(2):119-24. PubMed ID: 15846145
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Impact of aging on host immune response and survival in melanoma: an analysis of 3 patient cohorts.
    Weiss SA; Han J; Darvishian F; Tchack J; Han SW; Malecek K; Krogsgaard M; Osman I; Zhong J
    J Transl Med; 2016 Oct; 14(1):299. PubMed ID: 27760559
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A retrospective observational study of primary cutaneous malignant melanoma patients treated with excision only compared with excision biopsy followed by wider local excision.
    McKenna DB; Lee RJ; Prescott RJ; Doherty VR
    Br J Dermatol; 2004 Mar; 150(3):523-30. PubMed ID: 15030337
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prognosis of thick cutaneous melanoma.
    Kim SH; Garcia C; Rodriguez J; Coit DG
    J Am Coll Surg; 1999 Mar; 188(3):241-7. PubMed ID: 10065812
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Clinicopathologic Features and Prognostic Factors of Primary Cutaneous Melanoma: a Multicenter Study in Korea.
    Kim JE; Chung BY; Sim CY; Park AY; Lee JS; Whang KU; Park YL; Kim HO; Park CW; Lee SY
    J Korean Med Sci; 2019 Apr; 34(16):e126. PubMed ID: 31020815
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Metastatic melanoma: prognostic factors and survival in patients with brain metastases.
    Frinton E; Tong D; Tan J; Read G; Kumar V; Kennedy S; Lim C; Board RE
    J Neurooncol; 2017 Dec; 135(3):507-512. PubMed ID: 28819707
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Metastatic pathways and time courses in the orderly progression of cutaneous melanoma.
    Meier F; Will S; Ellwanger U; Schlagenhauff B; Schittek B; Rassner G; Garbe C
    Br J Dermatol; 2002 Jul; 147(1):62-70. PubMed ID: 12100186
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Clinical and pathologic factors associated with distant metastasis and survival in patients with thin primary cutaneous melanoma.
    Murali R; Haydu LE; Long GV; Quinn MJ; Saw RP; Shannon K; Spillane AJ; Stretch JR; Kefford RF; Thompson JF; Scolyer RA
    Ann Surg Oncol; 2012 Jun; 19(6):1782-9. PubMed ID: 22350600
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prognostic Significance of Periadnexal Extension in Cutaneous Melanoma and its Implications for Pathologic Reporting and Staging.
    Dodds TJ; Lo S; Jackett L; Nieweg O; Thompson JF; Scolyer RA
    Am J Surg Pathol; 2018 Mar; 42(3):359-366. PubMed ID: 29240580
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Locoregional cutaneous metastasis in patients with therapeutic lymph node dissection for malignant melanoma: risk factors and prognostic impact.
    Kretschmer L; Preusser KP; Neumann C
    Melanoma Res; 2002 Oct; 12(5):499-504. PubMed ID: 12394192
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Risk factors related to late metastases in 1,372 melanoma patients disease free more than 10 years.
    Osella-Abate S; Ribero S; Sanlorenzo M; Maule MM; Richiardi L; Merletti F; Tomasini C; Marra E; Macripò G; Fierro MT; Quaglino P
    Int J Cancer; 2015 May; 136(10):2453-7. PubMed ID: 25331444
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Risk Factors for Lymphatic and Hematogenous Dissemination in Patients With Stages I to II Cutaneous Melanoma.
    Calomarde-Rees L; García-Calatayud R; Requena Caballero C; Manrique-Silva E; Traves V; García-Casado Z; Soriano V; Kumar R; Nagore E
    JAMA Dermatol; 2019 Jun; 155(6):679-687. PubMed ID: 31042264
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.